NCT02104310View on ClinicalTrials.gov

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Active, not recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 26, 2021

Study Completion Date

March 31, 2031

Conditions
Malignant Glioma
Interventions
DRUG

Fluorine-18-L-dihydroxyphenylalanine

5 millicuries ± 10%; Intravenous injection; 1 time

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Brains Together for the Cure

UNKNOWN

lead

Mayo Clinic

OTHER

NCT02104310 - A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas | Biotech Hunter | Biotech Hunter